SignaTalk Series Featuring New Signatera CRC Data
On Thursday, January 28th Dr. Angle Rodrigues and Dr. Alexey Aleshin discussed how the latest ASCO GI data can be applied to better stratify high risk patients and the emerging role of ctDNA to better monitor GI cancers.